"Vaccines, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
Descriptor ID |
D014614
|
MeSH Number(s) |
D12.776.828.868 D20.215.894.865 D23.050.865
|
Concept/Terms |
Vaccines, Synthetic- Vaccines, Synthetic
- Synthetic Vaccines
- Synthetic Immunogens
- Immunogens, Synthetic
Molecular Vaccines- Molecular Vaccines
- Vaccines, Molecular
- Vaccines, Chemical
- Chemical Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Synthetic".
This graph shows the total number of publications written about "Vaccines, Synthetic" by people in this website by year, and whether "Vaccines, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 1 | 2 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 3 | 4 |
2005 | 4 | 3 | 7 |
2007 | 0 | 2 | 2 |
2008 | 1 | 3 | 4 |
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 1 | 3 | 4 |
2012 | 0 | 2 | 2 |
2013 | 0 | 6 | 6 |
2014 | 1 | 5 | 6 |
2015 | 0 | 4 | 4 |
2016 | 1 | 6 | 7 |
2017 | 11 | 32 | 43 |
2018 | 5 | 31 | 36 |
2019 | 5 | 15 | 20 |
2020 | 9 | 22 | 31 |
2021 | 41 | 63 | 104 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines, Synthetic" by people in Profiles.
-
Comparison of Anti-SARS-CoV-2 S1 Receptor-Binding Domain Antibody Immunoassays in Health Care Workers Before and After the BNT162b2 mRNA Vaccine. Am J Clin Pathol. 2022 02 03; 157(2):212-218.
-
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination. Clin Chem. 2021 12 30; 68(1):251-253.
-
Nucleic acid vaccines and CpG oligodeoxynucleotides for allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2021 12 01; 21(6):569-575.
-
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial. Emerg Microbes Infect. 2021 Dec; 10(1):1589-1597.
-
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination. Emerg Microbes Infect. 2021 Dec; 10(1):1390-1403.
-
SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271.
-
Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 10 12; 326(14):1390-1399.
-
Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138.
-
Persistent Immunogenicity of the mRNA COVID-19 Vaccine in Patients Vaccinated Before Kidney Transplant. Transplantation. 2021 10 01; 105(10):e133-e134.
-
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J. 2021 10 01; 40(10):e360-e363.